Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2197-2200, October 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halpin, Z. T.
Right arrow Articles by Blair, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halpin, Z. T.
Right arrow Articles by Blair, P. B.

Lack of Antigenicity of Mammary Tumors Induced by Carcinogens in a Nonantigenic Preneoplastic Lesion1

Zuleyma Tang Halpin, Jan Vaage2 and Phyllis B. Blair

Cancer Research Laboratory and Department of Bacteriology and Immunology, University of California, Berkeley, California 94720

Eight mammary carcinomas were induced by either 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene in a nonviral- and noncarcinogen-induced preneoplastic (premalignant) alveolar nodule which had arisen in a hormonally stimulated BALB/c female mouse. The preneoplastic mammary nodule outgrowth was found to be nonantigenic when tested in the strain of origin. Seven of the eight carcinogen-induced carcinomas were also found to exhibit no clear-cut evidence of antigenicity. The eighth tumor, however, was shown to produce tumor-specific immunity in BALB/c mice.

The results suggest that carcinogens may not directly induce the appearance of new antigens in the tumors they produce. Furthermore, carcinogens may act in a different manner when inducing a preneoplastic change than when inducing a tumor from a preexisting preneoplastic lesion.

1 This work was supported by NIH Grants CA-5388 and CA-5045, by Grant PRA-37 from the American Cancer Society, and by cancer research funds of the University of California, Berkeley, Calif. 94720.

2 Present address: Department of Radiation Medicine, Massachusetts General Hospital, Boston, Mass. 02114.

Received 3/10/72. Accepted 6/23/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.